National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Case
No judgment structure available for this case.

Statutory Rules

1977 No. 125

REGULATIONS UNDER THE NATIONAL HEALTH ACT-1953.*

WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953 that a drug or medicinal preparation that was not a pharmaceutical benefit under that Act immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953, namely the drugs and medicinal preparations specified in Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

Dated this twenty fifth day of July, 1977

 

Governor-General.

By His Excellency’s Command,

(Sgd. Ralph J. Hunt)

Minister of State for Health.

_______

 

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1. These Regulations shall come into operation on 1 August 1977.

_________________________________________________________________________________

* Notified in the Commonwealth of Australia Gazette on 29 July 1977.

  Statutory Rules 1960, No. 17 as amended to date. For previous amendments of the National Health (Pharmaceutical Benefits) Regulations see footnote   to Statutory Rules 1977, No. 39 and see also Statutory Rules 1977, No. 39.

      

13860/77 Cat. No. —Recommended retail price 60c 12/18.7.1977

Schedules 1, 2, 3, 4 and 5.

2. Schedules 1, 2, 3, 4 and 5 to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules substituted:—

 SCHEDULE 1  Sub-regulations 10 (1) and (2)

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as or, except as specially provided, used in pharmaceutical benefits

1 Acetarsol

63 Carbachol Injection

2 Acetomenaphthone

64 Carbamazepine

3 Acetomenaphthone Tablets

65 Carbenoxolone Sodium

4 Acetrizoic Acid

66 Carbimazole

5 Alcohol, Dehydrated

67 Carbomer

6 Alcohol (95%)

68 Carbon Dioxide

7 Allopurinol

69 Carbromal

8 Almond Oil

70 Cardamom Fruit

9 Aloes

71 Cascara

10 Alprenolol Hydrochloride

72 Cascara Dry Extract

11 Aluminium Glycinate

73 Cascara Liquid Extract

12 Aluminium Hydroxide Tablets

74 Cascara Tablets

13 Aluminium Phosphate Gel

75 Castor Oil

14 Aluminium Phosphate Gel, Dried

76 Catgut, Sterilised Surgical

15 Aluminium Phosphate Tablets

77 Cellulose, Oxidised

16 Amethocaine Hydrochloride

78 Cetomacrogol 1000

17 Amodiaquine Tablets

79 Cetylpyridinium Chloride

18 Amphetamine Sulphate

80 Chlorambucil

19 Amphetamine Sulphate Tablets

81 Chlorcyclizine Hydrochloride

20 Amylobarbitone Sodium Tablets

82 Chlordiazepoxide Capsules

21 Antazoline Hydrochloride

83 Chlordiazepoxide Hydrochloride

22 Antazoline Tablets

84 Chlorhexidine Gluconate Solution

23 Anti-D (Rho) Immunoglobulin Injection

85 Chlorhexidine Hydrochloride

24 Antimony Sodium Tartrate

86 Chlormerodrin (197 Hg) Injection

25 Antimony Sodium Tartrate Injection

87 Chloroform

26 Apomorphine Hydrochloride

88 Chloroquine Phosphate Injection

27 Apomorphine Injection

89 Chloroquine Sulphate

28 Arachis Oil

90 Chlorothiazide

29 Aspirin and Caffeine Tablets

91 Chlorotrianisene

30 Aspirin and Codeine Tablets

92 Chlorotrianisene Capsules

31 Aspirin and Codeine Tablets, Soluble

93 Chlorphenesin

32 Aspirin, Phenacetin and Codeine Tablets

94 Chlorpheniramine Injection

33 Aspirin, Phenacetin and Codeine Tablets,

95 Chlorproguanil Hydrochloride

Soluble

96 Chlorproguanil Tablets

34 Azathioprine

97 Chlorpropamide

35 Bacillus Calmette-Guérin Vaccine

98 Chlorthalidone

36 Barbitone Sodium

99 Choline Theophyllinate Tablets

37 Barbitone Sodium Tablets

100 Cinchocaine Hydrochloride

38 Barium Sulphate

101 Cinnamon

39 Belladonna Dry Extract

102 Clofibrate

40 Belladonna Herb

103 Clomiphene Citrate

41 Bendrofluazide

104 Clomiphene Tablets

42 Benzhexol Hydrochloride

105 Cochineal

43 Benzyl Alcohol

106 Cod-liver Oil

44 Benzylpenicillin Tablets

107 Colchicine

45 Betamethasone Sodium Phosphate Tablets

108 Colchicum Corm

46 Bethanidine Sulphate

109 Colchicum Liquid Extract

47 Biperiden

112 Colophony

48 Bisacodyl Tablets

113 Concentrated Peppermint Water

49 Bupivacaine Hydrochloride

114 Coriander

50 Busulphan

115 Coriander Oil

51 Butobarbitone

116 Corticotrophin

52 Butylated Hydroxyanisole

117 Corticotrophin Injection

53 Butylated Hydroxytoluene

118 Corticotrophin Gelatin Injection

54 Caffeine Hydrate

119 Corticotrophin Zinc Injection

55 Calciferol Solution

120 Cortisone Acetate

56 Calcium Aminosalicylate

121 Cortisone Injection

57 Calcium Gluconate Injection

122 Cresol

58 Calcium Lactate

123 Crotamiton

59 Calcium Lactate Tablets

124 Cyanocobalamin

60 Camphor

125 Cyanocobalamin (57 Co)

61 Candicidin

126 Cyanocobalamin (57 Co)

62 Caraway

Schedule 1—continued

127 Cyclobarbitone Calcium

194 Domiphen Bromide

128 Cyclomethycaine Sulphate

195 Dothiepin Capsules

129 Cyclopenthiazide

196 Dothiepin Hydrochloride

130 Cyclopentolate Hydrochloride

197 Dried Human Albumin

131 Cyclopropane

198 Dydrogesterone

132 Cycloserine

199 Dydrogesterone Tablets

133 Cycloserine Tablets

200 Edrophonium Chloride

134 Dapsone

201 Edrophonium Injection

135 Demeclocycline Hydrochloride

202 Eltor Vaccine

136 Deoxycortone Acetate

203 Emetine and Bismuth Iodide

137 Deoxycortone Acetate Implants

204 Emetine Hydrochloride

138 Deoxycortone Acetate Injection

205 Emetine Injection

139 Dequalinium Acetate

206 Erythromycin Estolate Capsules

140 Dequalinium Chloride

207 Ethacrynic Acid

141 Desipramine Hydrochloride

208 Ethambutol Hydrochloride

142 Dexamphetamine Sulphate

209 Ethambutol Tablets

143 Dextran 110 Injection

210 Ethchlorvynol

144 Dextromethorphan Hydrobromide

211 Ethchlorvynol Capsules

145 Dextromethorphan Tablets

212 Ether Anaesthetic

146 Dextropropoxyphene Capsules

213 Ether Solvent

147 Dextropropoxyphene Napsylate

214 Ethionamide

148 Dextrose

215 Ethionamide Tablets

149 Diamorphine Hydrocloride

216 Ethisterone

150 Diamorphine Injection

217 Ethisterone Tablets

151 Diazepam Capsules

218 Ethopropazine Hydrochloride

152 Diazoxide

219 Ethotoin

153 Diazoxide Tablets

220 Ethotoin Tablets

154 Dibromopropamidine Isethionate

221 Ethyl Chloride

155 Dichloralphenazone

222 Ethyloestrenol

156 Dichloralphenazone Tablets

223 Ethyl Oleate

157 Dichlorophen

224 Ethylenediamine Hydrate

158 Dichlorophen Tablets

225 Eucalyptus Oil

159 Dichlorphenamide

226 Eugenol

160 Dicophane

227 Fenfluramine Hydrochloride

161 Dicyclomine Tablets

228 Fenfluramine Tablets

162 Diethylcarbamazine Citrate

229 Ferric Citrate (50 Fe) Injection

163 Diethylcarbamazine Tablets

230 Ferrous Fumarate

164 Diethyltoluamide

231 Ferrous Succinate

165 Digitalis Leaf

232 Ferrous Succinate Capsules

166 Digitalis, Prepared

233 Ferrous Succinate Tablets

167 Digitalis Tablets, Prepared

234 Ferrous Sulphate Tablets

168 Digitoxin

235 Fludrocortisone Acetate

169 Digitoxin Tablets

236 Flufenamic Acid

170 Digoxin Paediatric Injection

237 Flufenamic Acid Capsules

171 Dihydrocodeine Injection

238 Fluorescein Sodium

172 Dihydrocodeine Tablets

239 Fluoxymesterone

173 Di-iodohydroxyquinoline Tablets

240 Fluphenazine Decanoate

174 Diloxanide Furoate

241 Fluphenazine Enanthate

175 Dilute Alcohols

242 Fractionated Coconut Oil

176 Dimenhydrinate

243 Fractionated Palm Kernel Oil

177 Dimenhydrinate Injection

244 Frusemide

178 Dimenhydrinate Tablets

245 Gallamine Injection

179 Dimercaprol

246 Gallamine Triethiodide

180 Dimethisterone

247 Gelatin Sponge, Absorbable

181 Dimethisterone Tablets

248 Gentamicin Sulphate

182 Dimethyl Phthalate

249 Gentian

183 Dimethyl Sulphoxide

250 Ginger

184 Diodone Injection

251 Glibenclamide

185 Diphenhydramine Injection

252 Globin Zinc Insulin Injection

186 Diphtheria Vaccine

253 Glucagon

187 Diphtheria and Tetanus Vaccine

254 Glutethimide

188 Diphtheria, Tetanus and Pertussis Vaccine

255 Glutethimide Tablets

189 Diphtheria, Tetanus and Poliomyelitis Vaccine

256 Gold (198Au) Injection

190 Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine

257 Griseofulvin

191 Dipipanone Hydrochloride

258 Guanethidine Monosulphate

192 Dipipanone Injection

259 Halibut-liver Oil

193 Dodecyl Gallate

260 Halibut-liver Oil Capsules

261 Halothane

262 Halquinol

263 Helium

Schedule 1—continued

264 Heparin

324 Levorphanol Tablets

265 Hexachlorophane

325 Levorphanol Tartrate

266 Hexylresorcinol

326 Lignocaine and Adrenaline Injection

267 Histamine Acid Phosphate

327 Lincomycin Capsules

268 Histamine Acid Phosphate Injection

328 Liothyronine Sodium

269 Human Albumin

329 Liquorice

270 Human Albumin Fraction (Saline)

330 Lithium Carbonate

271 Human Albumin Fraction (Saline),

331 Lymecycline

Dried

332 Lymecycline and Procaine Injection

272 Human Antihaemophilic Fraction,

333 Lymecycline Capsules

Dried

334 Macrosalb (131I) Injection

273 Human Antitetanus Immunoglobulin

335 Macrogol 300

Injection

336 Macrogol 1540

274 Human Antivaccinia Immunoglobulin Injection

337 Macrogol 4000

275 Human Blood, Whole

338 Magnesium Stearate

276 Human Fibrinogen, Dried

339 Maize Oil

277 Human Fibrinogen for Isotopic Labelling,

340 Male Fern

Dried

341 Male Fern Extract

278 Human Normal Immunoglobulin

342 Maleic Acid

Injection

343 Mannitol

279 Human Plasma, Dried

344 Measles Vaccine (Live Attenuated)

280 Human Red Blood Corpuscles,

345 Mefenamic Acid

Concentrated

346 Mefenamic Acid Capsules

281 Human Serum, Dried

347 Megestrol Acetate

282 Human Thrombin, Dried

348 Meglumine

283 Hydrocortisone Hydrogen Succinate

349 Meglumine Diatrizoate Injection

284 Hydrocortisone Ointment

350 Meglumine Iothalamate Injection

285 Hydroflumethiazide

351 Melarsoprol Injection

286 Hydroxocobalamin

352 Melphalan

287 Hydroxychloroquine Sulphate

353 Melphalan Injection

288 Hydroxyprogesterone Hexanoate

354 Mepacrine Hydrochloride

289 Hydroxyprogesterone Injection

355 Mepacrine Tablets

290 Hyoscine Injection

356 Mephentermine Injection

291 Hyoscine Eye Ointment

357 Mephentermine Sulphate

292 Hyoscine Tablets

358 Meprobamate

293 Hyoscyamus

359 Meprobamate Tablets

294 Ibuprofen

360 Mepyramine Injection

295 Indigo Carmine

361 Mepyramine Maleate

296 Indomethacin

362 Mepyramine Tablets

297 Influenza Vaccine

363 Mercaptopurine

298 Influenza Vaccine, Adsorbed

364 Mersalyl Acid

299 Industrial Methylated Spirit

365 Mersalyl Injection

300 Intracutaneous Typhoid-paratyphoid

366 Metaraminol Injection

A & B Vaccine

367 Metaraminol Tartrate

301 Inulin

368 Methacycline Hydrochloride

302 Inulin Injection

369 Methandienone

303 Iodinated (125 I) Human Albumin

370 Methaqualone

Injection

371 Methisazone

304 Iodinated (131 I) Human Albumin

372 Methisazone Mixture

Injection

373 Methohexitone Injection

305 Iodipamide Meglumine

374 Methoin

Injection

375 Methoserpidine

306 Iodised Oil Fluid Injection

376 Methoserpidine Tablets

307 Iopanoic Acid

377 Methoxyflurane

308 Iopanoic Acid Tablets

378 Methylamphetamine Hydrochloride

309 Iophendylate Injection

379 Methylamphetamine Injection

310 Iothalamic Acid

380 Methylamphetamine Tablets

311 Ipecacuanha

381 Methylcellulose 450

312 Ipecacuanha, Prepared

382 Methyldopa

313 Isocarboxazid

383 Methyldopate Hydrochloride

314 Isocarboxazid Tablets

384 Methyldopate Injection

315 Isoniazid

385 Methylergometrine Injection

316 Isopropyl Alcohol

386 Methylergometrine Maleate

317 Kanamycin Acid Sulphate

387 Methylprednisolone Tablets

318 Kanamycin Sulphate

388 Methylthiouracil

319 Laevulose

389 Methylthiouracil Tablets

320 Laevulose Injection

390 Methyprylone

321 Lemon Peel, Dried

391 Methyprylone Tablets

322 Levallorphan Injection

392 Metronidazole

323 Levorphanol Injection

393 Metyrapone

Schedule 1—continued

394 Metyrapone Capsules

463 Phenmetrazine Tablets

395 Morphine Sulphate Tablets

464 Phenobarbitone Sodium Tablets

396 Nalorphine Hydrobromide

465 Phenol and Glycerol Injection

397 Nandrolone Decanoate

466 Phenolphthalein Tablets

398 Nandrolone Phenylpropionate

467 Phenoxybenzamine Capsules

399 Neostigmine Bromide

468 Phenoxybenzamine Hydrochloride

400 Nialamide

469 Phenoxymethylpenicillin

401 Nialamide Tablets

470 Phenoxymethylpenicillin Calcium

402 Niclosamide

471 Phenoxymethylpenicillin Potassium

403 Nicotinamide

472 Phentolamine Injection

404 Nicotinic Acid

473 Phentolamine Mesylate

405 Nicoumalone

474 Phenylephrine Injection

406 Nikethamide

475 Phenylpropanolamine Hydrochloride

407 Nikethamide Infection

476 Phosphoric Acid

408 Nitrazepam

477 Phytomenadione Tablets

409 Nitrous Oxide

478 Piperazine Adipate

410 Norethandrolone

479 Piperazine Adipate Tablets

411 Norethandrolone Tablets

480 Piperazine Citrate

412 Noscapine

481 Piperazine Phosphate Tablets

413 Novobiocin Calcium

482 Poldine Methylsulphate

414 Novobiocin Sodium

483 Poldine Tablets

415 Novobiocin Tablets

484 Poliomyelitis Vaccine (Inactivated)

416 Nux Vomica

485 Poliomyelitis Vaccine (Oral)

417 Octaphoniurn Chloride

486 Potassium Bromide

418 Octyl Gallate

487 Potassium Chloride and Dextrose Injection

419 Oestradiol Benzoate

488 Potassium Chloride and Sodium Chloride Injection

420 Oestradiol Benzoate Injection

489 Potassium Chloride Tablets

421 Olive Oil

490 Potassium Hydroxide

422 Opium

491 Potassium Nitrate

423 Opium, Powdered

492 Practolol

424 Orange Peel, Dried Bitter

493 Practolol Injection

425 Orciprenaline Injection

494 Practolol Tablets

426 Orphenadrine Citrate

495 Prednisolone Pivalate

427 Orphenadrine Hydrochloride

496 Prednisolone Pivalate Injection

428 Oxygen

497 Prednisolone Sodium Phosphate

429 Oxyphenbutazone

Injection

430 Oxyphenbutazone Tablets

498 Prednisone

431 Oxyphencyclimine Hydrochloride

499 Pregelatinised Maize Starch

432 Oxyphencyclimine Tablets

500 Prilocaine Hydrochloride

433 Oxytetracycline Tablets

501 Primaquine Phosphate

434 Oxytocin Tablets

502 Probenecid

435 Papaverine Hydrochloride

503 Procainamide Tablets

436 Paramethadione

504 Procaine and Adrenaline

437 Paramethadione Capsules

Injection

438 Penicillamine

505 Prochlorperazine Maleate

439 Penicillamine Hydrochloride

506 Prochlorperazine Mesylate

440 Pentaerythritol Tablets

507 Procyclidine Hydrochloride

441 Pentagastrin

508 Progesterone

442 Pentagastrin Injection

509 Progesterone Injection

443 Pentamidine Injection

510 Proguanil Hydrochloride

444 Pentamidine Isethionate

511 Promazine Hydrochloride

445 Pentazocine

512 Promazine Injection

446 Pentazocine Hydrochloride

513 Promazine Tablets

447 Pentazocine Tablets

514 Promethazine Theoclate

448 Pentolinium Tartrate

515 Propanidid

449 Peppermint Oil

516 Propantheline Bromide

450 Percutaneous Bacillus Calmette-Guérin Vaccine

517 Propantheline Tablets

451 Perphenazine

518 Propicillin Potassium

452 Perphenazine Tablets

519 Propicillin Tablets

453 Pertussis Vaccine, Adsorbed

520 Propranolol Hydrochloride

454 Pethidine Tablets

521 Propyl Gallate

455 Phenacetin

522 Propyliodone

456 Phenazocine Hydrobromide

523 Propyliodone Injection

457 Phenazocine Injection

524 Propyliodone Oily Injection

458 Phenazocine Tablets

525 Propylthiouracil

459 Phenelzine Sulphate

526 Pyrazinamide

460 Phenindamine Tartrate

527 Pyridostigmine Bromide

461 Phenindione

528 Pyrimethamine

462 Phenmetrazine Hydrochloride

529 Pyroxylin

Schedule 1—continued

530 Quillaia

594 Sulphomyxin Injection

531 Quinine Bisulphate

595 Sulphomyxin Sodium

532 Quinine Dihydrochloride

596 Sulthiame

533 Quinine Dihydrochloride Injection

597 Suxamethonium Bromide

534 Quinine Hydrochloride

598 Suxamethonium Bromide Injection

535 Quinine Sulphate

599 Suxamethonium Chloride

536 Rabies Antiserum

600 Suxamethonium Chloride Injection

537 Rubella Vaccine (Live Attenuated)

601 Tartaric Acid

538 Saccharin

602 Testosterone

539 Saccharin Sodium

603 Testosterone Implants

540 Secbutobarbitone

604 Testosterone Phenylpropionate

541 L-Selenomethionine (75 Se) Injection

Injection

542 Senna Fruit

605 Tetanus and Pertussis Vaccine

543 Senna Tablets

606 Tetanus Antitoxin

544 Sesame Oil

607 Tetanus Vaccine

545 Silver Nitrate, Toughened

608 Tetrachloroethylene

546 Slow Lithium Carbonate Tablets

609 Tetrachloroethylene Capsules

547 Slow Orphenadrine Citrate Tablets

610 Tetracycline Injection

548 Smallpox Vaccine, Dried

611 Tetracycline Tablets

549 Soda Lime

612 Theobroma Oil

550 Sodium Acetrizoate Injection

613 Thiambutosine

551 Sodium Aminosalicylate

614 Thiamine Hydrochloride

552 Sodium Aurothiomalate

615 Thiomersal

553 Sodium Bicarbonate Compound Tablets

616 Thiopentone Sodium

554 Sodium Bromide

617 Thiopentone Injection

555 Sodium Calciumedetate

618 Thymoxamine Hydrochloride

556 Sodium Chloride Tablets

619 Thymoxamine Tablets

557 Sodium Chromate (51 Cr) Solution

620 Thyroid

558 Sodium Citrate Tablets

621 Thyroxine Sodium

559 Sodium Diatrizoate

622 Tolazoline Hydrochloride

560 Sodium Diatrizoate Injection

623 Tolazoline Tablets

561 Sodium Fluoride

624 Tolbutamide

562 Sodium Fusidate Capsules

625 Tolnaftate

563 Sodium Hydroxide

626 Tranylcypromine Sulphate

564 Sodium Iodide (131 I) Injection

627 Triamterene Capsules

565 Sodium Iodide (125 I) Solution

628 Trichloroethylene

566 Sodium Iodide (131 I) Solution

629 Triclofos Tablets

567 Sodium Iodohippurate (131 I) Injection

630 Trimipramine Maleate

568 Sodium Iothalamate Injection

631 Tropicamide

569 Sodium Lauryl Sulphate

632 Troxidone

570 Sodium Methyl Hydroxybenzoate

633 Tuberculin, Old

571 Sodium Pertechnetate (99/?/ Tc) Injection

634 Tuberculin Purified Protein Derivative

572 Sodium Phosphate (32 P) Injection

635 Tubocurarine Chloride

573 Sodium Propyl Hydroxybenzoate

636 Tubocurarine Injection

574 Sodium Stibogluconate

637 Turpentine Oil

575 Sodium Stibogluconate Injection

638 Typhoid and Tetanus Vaccine

576 Sorbitol

639 Typhoid-paratyphoid A and B Vaccine

577 Sorbitol Injection

640 Typhoid-paratyphoid A and B and Tetanus Vaccine

578 Spironolactone

641 Typhoid-paratyphoid A and B and Cholera Vaccine

579 Stanolone

642 Undecenoic Acid

580 Sterilizable Maize Starch

643 Urea Injection

581 Stilboestrol

644 Vasopressin Injection

582 Stramonium

645 Vinyl Ether

583 Strong Potassium Chloride Solution

646 Viomycin Sulphate

584 Sulphacetamide Eye Ointment

647 Viomycin Sulphate

585 Sulphadimethoxine

Injection

586 Sulphadimethoxine Tablets

648 Vitamin A Ester

587 Sulphadimidine injection

Concentrate

588 Sulphadimidine Sodium

649 Warfarin Sodium

589 Sulphamethoxydiazine

650 Xenon (133Xe) Injection

590 Sulphamethoxypyridazine

651 Xylose

591 Sulphapyridine

652 Yellow Fever Vaccine

592 Sulphinpyrazone

653 Zinc Undecenoate

593 Sulphobromophthalein Sodium

654 Zinc Undecenoate Ointment

SCHEDULE 2  Sub-regulations 10 (3) and (4)

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

1

Acepifylline...................................................................

2

Acetylcysteine..............................................................

3

Acetylsulphafurazole..................................................

4

Acrylic Resin................................................................

5

Adrenaline Hydrochloride .........................................

6

“ ALBUMAID XP ”....................................................

7

Alginic Acid Compound............................................

8

Aluminium Sodium Silicate.......................................

9

Amiloride Hydrochloride

Hydrochlorothiazide, B.P., with Amiloride Hydrochloride

10

Aminocaproic Acid......................................................

11

“ AMINOFUSIN 5% ”................................................

12

“ AMINOFUSIN 10% ”.............................................

13

“ AMINOFUSIN A 5% WITH ALCOHOL............

14

“ AMINOFUSIN STANDARD ”.............................

15

“ AMINOGRAN ”.......................................................

16

Amoxycillin Trihydrate..............................................

Purified Water, B.P., with Amoxycillin Trihydrate

17

Amphotericin................................................................

18

Ampicillin......................................................................

19

Ampicillin Trihydrate.................................................

Purified Water, B.P., with Ampicillin Trihydrate

20

Antazoline Sulphate....................................................

Naphazoline Nitrate with Antazoline Sulphate

21

Ascorbic Acid...............................................................

Ferrous Sulphate mixture and Ferrous Sulphate mixture C.F. of the Australian Pharmaceutical Formulary

Ferrous Sulphate mixture Prescribers’ List

Ferrous Sulphate mixture Prescribers’ List Children’s Section

22

Bacitracin......................................................................

Neomycin Sulphate with Polymyxin B Sulphate and Bacitracin

23

Bacitracin Zinc.............................................................

Neomycin Undecenoate with Bacitracin Zinc

Polymyxin B Sulphate with Neomycin Sulphate and Bacitracin Zinc

24

“ BANISH ”..................................................................

25

Beclomethasone Dipropionate

26

Benzathine Penicillin...................................................

Procaine Penicillin with Benzylpenicillin Potassium and Benzathine Penicillin

27

Benzylpenicillin Potassium.......................................

Benzathine Penicillin with Procaine Penicillin and Benzylpenicillin Potassium

28

Benzylpenicillin Sodium............................................

Procaine Penicillin with Benzylpenicillin Sodium

29

Betamethasone............................................................

Betamethasone Acetate with Betamethasone

30

Betamethasone Acetate..............................................

Betamethasone with Betamethasone Acetate

31

Betamethasone Sodium Phosphate

32

Betamethasone Phosphate.........................................

33

Bisacodyl.......................................................................

Dioctyl Sodium Sulphosuccinate, B.P.C., with Bisacodyl

34

Brompheniramine Maleate........................................

35

Bufexamac...................................................................

36

Calciferol.......................................................................

37

Calcium Chloride.........................................................

Sodium Chloride, B.P., with Potassium Chloride and Calcium Chloride in Water for Injections

38

Calcium Lactate-Gluconate.......................................

Calcium Carbonate, B.P., with Calcium Lactate-Gluconate

39

Carbachol......................................................................

Hypromellose 4500 with Carbachol

40

Carbidopa.....................................................................

Levodopa, B.P., with Carbidopa

41

Carbinoxamine Maleate.............................................

42

Cephradine....................................................................

Purified Water, B.P., with Cephradine

43

Ceratonia, B.P.C. 1949...............................................

44

Chloramine, B.P.C.......................................................

45

Chloramphenicol.........................................................

Polymyxin B Sulphate with Chloramphenicol

46

Chloramphenicol Palmitate, B.P.C.

Schedule 2—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

47

Chloramphenicol Stearate..........................................

48

Chlorhexidine Gluconate...........................................

49

Chlorpheniramine Maleate........................................

50

Chlorpromazine Hydrochloride

31

Choline Theophyllinate..............................................

Guaiphenesin, B.P.C., with Choline Theophyllinate

52

Clemastine Fumarate..................................................

53

Clemizole Tannate......................................................

54

Clindamycin Palmitate Hydrochloride

Purified Water, B.P., with Clindamycin Palmitate Hydrochloride

55

Cloxacillin Sodium......................................................

Purified Water, B.P., with Cloxacillin Sodium

56

Colistin Sulphate.........................................................

Neomycin Sulphate with Colistin Sulphate

57

Cortisone Acetate........................................................

58

Cyclizine Hydrochloride............................................

Ergotamine Tartrate with Caffeine and Cyclizine Hydrochloride

59

Cyproheptadine Hydrochloride

60

Danthron.......................................................................

Dioctyl Sodium Sulphosuccinate, B.P.C., with Danthron

61

Demecarium Bromide.................................................

62

Dexamethasone...........................................................

Framycetin Sulphate with Gramicidin and Dexamethasone

63

Dexamethasone Metasulphobenzoate

Framycetin Sulphate with Gramicidin and Dexamethasone Metasulphobenzoate

64

Dexchlorpheniramine Maleate

65

Dextropropoxyphene Hydrochloride

Paracetamol with Dextropropoxyphene Hydrochloride

66

Diazepam......................................................................

67

Dicyclomine Hydrochloride.......................................

Doxylamine Succinate with Pyridoxine Hydrochloride and Dicyclomine Hydrochloride

68

Dienoestrol....................................................................

69

“ DIGESTELACT ”....................................................

70

Digoxin...........................................................................

71

Dihydrocodeine Tartrate............................................

72

Dimethicone, B.P.C.....................................................

73

Dioctyl Sodium Sulphosuccinate, B.P.C.

Bisacodyl with Dioctyl Sodium Sulphosuccinate, B.P.C.

Danthron with Dioctyl Sodium Sulphosuccinate, B.P.C.

74

Diphenhydramine Hydrochoride

Ergotamine Tartrate with Caffeine Citrate and Diphenhydramine Hydrochloride

75

Diphenoxylate Hydrochloride

Atropine Sulphate with Diphenoxylate Hydrochloride

76

Diphenylpyraline Hydrochloride

77

Diphtheria Vaccine Adsorbed

Diphtheria and Tetanus Vaccine, Adsorbed

Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed

78

Doxylamine Succinate................................................

Dicyclomine Hydrochloride with Pyridoxine Hydrochloride and Doxylamine Succinate

79

Ecothiopate Iodide......................................................

80

Ergometrine Maleate..................................................

Oxytocin with Ergometrine Maleate

81

Ergotamine Tartrate....................................................

Caffeine Citrate with Diphenhydramine Hydrochloride and Ergotamine Tartrate

Caffeine with Cyclizine Hydrochloride and Ergotamine Tartrate

Caffeine with Ergotamine Tartrate

Caffeine with Meclozine Hydrochloride and Ergotamine Tartrate

82

Erythromycin Estolate................................................

83

Erythromycin Stearate................................................

84

Ethinyloestradiol..........................................................

Ethynodiol Diacetate with Ethinyloestradiol

Lynoestrenol with, Ethinyloestradiol

Norethisterone Acetate with Ethinyloestradiol

Norgestrel with Ethinyloestradiol

85

Ethosuximide................................................................

86

Ethynodiol Diacetate..................................................

Ethinyloestradiol with Ethynodiol Diacetate

Mestranol with Ethynodiol Diacetate

Schedule 2—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

87

Fenoterol Hydrobromide...........................................

88

Ferrous Aminoacetosulphate

89

Fluclorolone Acetonide.............................................

90

Fluocinolone Acetonide.............................................

91

Fluocortolone Hexanoate..........................................

Fluocortolone Pivalate with Fluocortolone Hexanoate

92

Fluocortolone Pivalate...............................................

Fluocortolone Hexanoate with Fluocortolone Pivalate

93

Fluphenazine Hydrochloride

94

Flurandrenolone..........................................................

95

Folic Acid.....................................................................

Ferrous Sulphate (Dried), B.P., with Folic Acid, B.P.

96

Framycetin Sulphate..................................................

Dexamethasone with Framycetin Sulphate and Gramicidin

Gramicidin and Dexamethasone Metasulphobenzoate with Framycetin Sulphate

97

Fusidic Acid.................................................................

98

“ GALACTOMIN, FORMULA No. 17 ”

99

“ GALACTOMIN, FORMULA No. 19 ”

100

Glucose and Ketone Indicator

101

Glucose Indicator, Urine............................................

102

“ GLUCOSE NUTRAMIGEN ”

103

Goats’ Milk..................................................................

104

Goats’ Milk, Dehydrated..........................................

105

Gramicidin....................................................................

Framycetin Sulphate with Dexamethasone and Gramicidin

Framycetin Sulphate with Dexamethasone Metasulphobenzoate and Gramicidin

Neomycin Sulphate with Nystatin, Triamcinolone Acetonide and Gramicidin

Neomycin Sulphate with Thonzonium Bromide, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Gramicidin

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

106

Guaiphenesin, B.P.C...................................................

Theophylline with Guaiphenesin, B.P.C.

107

Hexamine Mandelate................................................

108

Hydrochlorothiazide, B.P..........................................

Amiloride Hydrochloride with Hydrochlorothiazide, B.P.

Triamterene, B.P., with Hydrochlorothiazide, B.P.

109

Hydrocortisone............................................................

Natamycin with Neomycin Sulphate and Hydrocortisone

Neomycin Sulphate with Hydrocortisone

.

Polymyxin B Sulphate with Neomycin Sulphate and Hydrocortisone

110

Hydrocortisone Acetate.............................................

Neomycin Sulphate with Gramicidin, Thonzonium Bromide, Thonzylamine Hydrochloride and Hydrocortisone Acetate

Neomycin Sulphate with Hydrocortisone Acetate

Oxytetracycline Hydrochloride and Hydrocortisone Acetate

111

Hyoscine Hydrobromide...........................................

Atropine Sulphate, B.P., with Hyoscyamine Sulphate and Hyoscine Hydrobromide, B.P.

Papaveretum with Hyoscine Hydrobromide, B.P.

112

Hyoscyamine Sulphate..............................................

Atropine Sulphate, B.P., with Hyoscine Hydrobromide, B.P., and Hyoscyamine Sulphate

113

Idoxuridine...................................................................

114

“ ISOMIL ”

115

Isoprenaline Hydrochloride.......................................

116

“ KETOVITE ” Liquid

117

Lauryldimethylbenzyl Ammonium Chloride

“ TERIC N8 ” with Lauryldimethylbenzyl Ammonium Chloride

118

Levallorphan Tartrate................................................

Pethidine Hydrochloride with Levallorphan Tartrate

119

Levodopa, B.P.............................................................

Carbidopa with Levodopa, B.P.

Schedule 2—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

120

Lincomycin Hydrochloride........................................

121

Locasol..........................................................................

122

Lofenalac......................................................................

123

Lynoestrenol.................................................................

Ethinylcestradiol with Lynoestrenol

Mestranol with Lynoestrenol

124

Lypressin.......................................................................

125

Magnesium Aluminium Hydroxide

126

Magnesium Chloride...................................................

Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride

127

Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel Dried with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel Dried with Magnesium Trisilicate and Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C.

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C., and Oxethazaine

128

Mebhydrolin Napadisylate, B.P.C. 1968

129

Meclozine Hydrochloride...........................................

Ergotamine Tartrate with Caffeine and Meclozine Hydrochloride

130

Medrysone....................................................................

131

Mestranol......................................................................

Ethynodiol Diacetate with Mestranol

Lynoestrenol with Mestranol

Norethisterone with Mestranol

Norethynodrel with Mestranol

132

Methdilazine Hydrochloride......................................

133

Methylprednisolone.....................................................

134

Morphine Tartrate.......................................................

Tacrine with Morphine Tartrate

135

Nalidixic Acid, B.P.C..................................................

136

Naphazoline Hydrochloride.......................................

137

Naphazoline Nitrate.....................................................

Antazoline Sulphate with Naphazoline Nitrate

138

Natamycin....................................................................

Neomycin Sulphate with Hydrocortisone and Natamycin

139

Neomycin Sulphate.....................................................

Bacitracin with Polymyxin B Sulphate and Neomycin Sulphate

Colistin Sulphate with Neomycin Sulphate

Gramicidin with Nystatin, Triamcinolone Acetonide and Neomycin Sulphate

Hydrocortisone Acetate with Neomycin Sulphate

Hydrocortisone with Neomycin Sulphate

Natamycin with Hydrocortisone and Neomycin Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Polymyxin B Sulphate with Gramicidin and Neomycin Sulphate

Polymyxin B Sulphate with Hydrocortisone, and Neomycin Sulphate

Thonzonium Bromide with Thonzylamine Hydrochloride, Hydrocortisone Acetate, Gramicidin and Neomycin Sulphate

140

Neomycin Undecenoate.............................................

Bacitracin Zinc with Neomycin Undecenoate

141

Neostigmine Methylsulphate

142

Nitrofurantoin...............................................................

143

Noradrenaline Acid Tartrate

144

Norethisterone

Mestranol with Norethisterone

145

Norethisterone Acetate...............................................

Ethinyloestradiol with Norethisterone Acetate

146

Norethynodrel...............................................................

Mestranol with Norethynodrel

147

Norgestrel.......................................................................

Ethinyloestradiol with Norgestrel

148

Nortriptyline Hydrochloride......................................

Schedule 2—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

149

Nystatin.........................................................................

Gramicidin with Neomycin Sulphate, Triamcinolone Acetonide and Nystatin

Oxytetracycline Dihydrate with Nystatin

Tetracycline, B.P.C., with a buffering agent and Nystatin

Tetracycline Hydrochloride with Nystatin

150

Orciprenaline Sulphate...............................................

151

Oxytetracycline Dihydrate.........................................

Nystatin with Oxytetracycline Dihydrate

152

Oxytetracycline Hydrochloride, B.P.

Hydrocortisone Acetate with Oxytetracycline Hydrochloride, B.P.

Polymyxin B Sulphate with Oxytetracycline Hydrochloride, B.P.

153

Oxethazaine.................................................................

Aluminium Hydroxide Gel with Magnesium Hydroxide, B.P.C., and Oxethazaine

154

Oxytocin........................................................................

Ergometrine Maleate with Oxytocin

155

Pancreatin.....................................................................

156

Pancreatin Enzyme, 4 times U.S.N.F.XIII strength

157

Papaveretum, B.P.C....................................................

Hyoscine Hydrobromide with Papaveretum, B.P.C.

158

Pericyazine....................................................................

159

Pertussis Vaccine.........................................................

Diphtheria, Tetanus and Pertussis Vaccine, Adsorbed

160

Pethidine Hydrochloride............................................

Levallorphan Tartrate with Pethidine Hydrochloride

161

Phenethicillin Potassium............................................

Purified Water, B.P., with Phenethicillin Potassium

162

Pheniramine Maleate..................................................

163

Phenolphthalein...........................................................

Paraffin Liquid, B.P., with Phenolphthalein, B.P.

164

Phenoxymethylpenicillin (Benzathine or Hydrabamine salt)

165

Phenytoin, B.P.C..........................................................

166

Pholcodine....................................................................

167

Pituitary (Posterior Lobe), Powdered, B.P.C.

168

“ PK AID I ”

169

“ PK AID II ”

170

Plasma Substitute (Polypeptide)

171

Polyisobutylene............................................................

172

Polymyxin B Sulphate................................................

Bacitracin with Neomycin Sulphate and Polymyxin B Sulphate

Chloramphenicol with Polymyxin B Sulphate

Lignocaine Hydrochloride with Propylene Glycol and Polymyxin B Sulphate

Neomycin Sulphate with Hydrocortisone and Polymyxin B Sulphate

Oxytetracycline Hydrochloride with Polymyxin B Sulphate

Polymyxin B Sulphate with Bacitracin Zinc and Neomycin Sulphate

Polymyxin B Sulphate with Neomycin Sulphate and Gramicidin

Propylene Glycol with Acetic Acid and Polymyxin B Sulphate

173

Polyvinylpyrrolidone and Vinyl Acetate Copolymer

174

Prednisolone.................................................................

175

Prednisolone Acetate..................................................

Phenylephrine Hydrochloride, B.P., with Prednisolone Acetate

176

Prednisolone Sodium Phosphate

177

“ PREGESTIMIL ”

178

Primidone......................................................................

Schedule 2—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

179

Procaine Penicillin........................................................

Benzathine Penicillin with Benzylpenicillin Potassium and Procaine Penicillin

Benzylpenicillin Sodium with Procaine Penicillin

180

Promethazine Hydrochloride

181

“ PROSOBEE ”............................................................

182

Pseudoephedrine Hydrochloride

183

Pyrantel Embonate......................................................

184

Pyridoxine Hydrochloride..........................................

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

185

Salbutamol....................................................................

186

Salbutamol Sulphate...................................................

187

“ SOBEE ”

188

Sodium Acetate............................................................

Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate

189

Sodium Acid Citrate....................................................

190

Sodium Carboxymethylcellulose

Gelatin and Pectin with Sodium Carboxymethylcellulose

191

Sodium Gluconate.......................................................

Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate

192

Sodium Lactate............................................................

Potassium Chloride with Anhydrous Dextrose and Sodium Lactate

193

“SOYALAC”.................................................................

194

Sterculia.........................................................................

195

Sulphafurazole.............................................................

196

Sulphamethizole...........................................................

197

Sulphamethoxazole.....................................................

Trimethoprim with Sulphamethoxazole

198

Sulphaphenazole, B.P.C..............................................

199

Surgical Cement...........................................................

200

Surgical Cement Solvent............................................

201

Tacrine...........................................................................

Morphine Sulphate with Tacrine

Morphine Tartrate with Tacrine

202

Terbutaline Sulphate...................................................

203

“TERIC N8”..................................................................

Lauryldimethylbenzyl Ammonium Chloride with “ TERIC N8 ”

204

Testosterone Decanoate.............................................

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

205

Testosterone Isocaproate............................................

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

206

Testosterone Phenylpropionate

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

207

Testosterone Propionate.............................................

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., and Testosterone Isocaproate

Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

208

Tetanus Vaccine, Adsorbed .......................................

Diphtheria and Tetanus Vaccine, Adsorbed

Diphtheria, Pertussis and Tetanus Vaccine, Adsorbed

209

Tetracyline, B.P.C........................................................

Tetracycline, B.P.C., with a buffering agent

Tetracycline, B.P.C., with a buffering agent and Nystatin

210

Tetracycline Hydrochloride........................................

Tetracycline Hydrochloride with Nystatin

211

Thioridazine Hydrochloride

212

Thiotepa.........................................................................

213

Thonzonium Bromide.................................................

Neomycin Sulphate with Gramicidin, Thonzylamine Hydrochloride, Hydrocortisone Acetate and Thonzonium Bromide

Schedule 2—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Allowable compounds (if any)

214

Thonzylamine Hydrochloride

Neomycin Sulphate with Gramicidin, Hydrocortisone Acetate, Thonzonium Bromide and Thonzylamine Hydrochloride

215

Triamcinolone Acetonide............................................

Gramicidin with Neomycin Sulphate, Nystatin and Triamcinolone Acetonide

216

Triamterene, B.P...........................................................

Hydrochlorothiazide, B.P. with Triamterene, B.P.

217

Triclofos Sodium..........................................................

218

Trifluoperazine Hydrochloride

219

“TRIGLYDE”................................................................

220

Trimeprazine Tartrate, B.P.C.

221

Trimethoprim................................................................

Sulphamethoxazole with Trimethoprim

222

Triprolidine Hydrochloride.........................................

223

Urea.................................................................................

224

Viprynium Embonate..................................................

225

“ZERODOR”.................................................................

226

“ZOFF”...........................................................................

SCHEDULE 3  Sub-regulation 10 (2)

regulation 11 and

sub-regulation 35 (1)

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

1 Acepifylline

61 Capsicum Ointment, B.P.C.

2 Acetazolamide Sodium

62 Carbidopa

3 Acetohexamide

63 Carbinoxamine Maleate

4 Acetylcholine Chloride

64 Cardamom Aromatic Tincture, B.P.C.

5 Acetylcysteine

65 Catechu Tincture, B.P.C.

6 Acetylsulphafurazole

66 Cephazolin Sodium

7 Acidified Golden Syrup, A.P.F. 1955

67 Cephradine

8 Acriflavine, B.P.C. 1963

68 Ceratonia, B.P.C. 1949

9 Acrylic Resin

69 Charcoal, B.P.C.

10 Adrenaline Hydrochloride

70 Chloramine, B.P.C.

11 “ ALBUMAID XP ”

71 Chloramphenicol Palmitate, B.P.C.

12 Alginic Acid Compound

72 Chloramphenicol Sodium Succinate

13 Aloxiprin

73 Chlorhexidine Gluconate

14 Aluminium Acetate Solution, B.P.C.

74 Chlorinated Lime, B.P.C.

15 Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex

75 Chlormethiazole

16 Aluminium Sodium Silicate

76 Chlormethiazole Edisylate

17 Amantadine Hydrochloride 18 Amaranth, B.P.C. 1954

77 Cholestyramine

19 Ambenonium Chloride

78 Clemastine Fumarate

20 Amiloride Hydrochloride

79 Clemizole Hydrochloride

21 Aminacrine Hydrochloride, B.P. 1968

80 Clemizole Tannate

22 “ AMINOFUSIN 5% ”

81 Clindamycin Hydrochloride

23 “ AMINOFUSIN 10% ”

82 Clindamycin Palmitate Hydrochloride

24 “ AMINOFUSIN A 5% WITH ALCOHOL ”

83 Clonazepam

25 “ AMINOFUSIN STANDARD ”

84 Clonidine Hydrochloride

26 “ AMINOGRAN ”

85 Clopamide

27 Amitriptyline Embonate, B.P.C.

86 Clorexolone

28 Ammonia Aromatic Spirit, B.P.C.

87 Coal Tar, B.P.C.

29 Ammonia Solution, Strong, B.P.C.

88 Coal Tar Solution, Strong, B.P.C.

30 Ammonium Acetate Solution, Strong,

89 Coconut Oil, B.P.C.

B.P.C.

90 Colaspase

31 Ammonium Bicarbonate, B.P.C.

91 Colophony Ointment, B.P.C. 1959

32 Angiotensin Amide

92 Copper Sulphate, B.P.C.

33 Antazoline Sulphate

93 Creosote, B.P.C. 1959

34 Anthrax Antiserum

94 Cyclothiazide

35 Anthrax Vaccine

95 Cycrimine Hydrochloride

36 Anti-Haemophilic Factor of Animal

96 Cytarabine Hydrochloride

Origin

97 Daunorubicin

37 Atropine, B.P.C.

98 Death Adder Antivenene

38 Azatadine Maleate

99 Debrisoquine

39 Bacitracin, B.P. 1968

100 Demecarium Bromide

40 Baclofen

101 Dexamethasone Metasulphobenzoate

41 “ BANISH ”

102 Dexamethasone Sodium Phosphate

42 Benzalkonium Chloride

103 Dexchlorpheniramine Maleate

43 Benzoin Compound Tincture, B.P.C.

104 Dibenzepin Hydrochloride

44 Betamethasone Acetate

105 “ DIGESTELACT ”

45 Betamethasone Phosphate

106 Dihydroergotamine Mesylate

46 Bethanechol Chloride

107 Dimethicone, B.P.C.

47 Biperiden Hydrochloride

108 Dimethindene Maleate

48 Bismuth Subgallate, B.P.C.

109 Dioctyl Sodium Sulphosuccinate, B.P.C.

49 Black Snake Antivenene

110 Diphemanil Methylsulphate

50 Bleomycin Sulphate

111 Diphtheria and Tetanus Vaccine, Adsorbed, B.P., Diluted

51 Brompheniramine Maleate

112 Diphtheria Vaccine, Adsorbed, B.P., Diluted

52 Brown Snake Antivenene

113 Dipyridamole

53 Buchu Concentrated Infusion, B.P.C. 1954

114 Doxylamine Succinate

54 Bufexamac

115 Droperidol

55 Cade Oil, B.P.C.

116 Ephedrine, B.P.C.

56 Caffeine Citrate, B.P.C

117 Epicillin

. 1959

118 Epicillin Sodium

57 Calcitonin (Salmon Synthetic)

119 Erythromycin Ethylsuccinate

58 Calcium Folinate

120 Erythromycin Gluceptate

59 Calcium Glubionate

121 Erythromycin Lactobionate

60 Calcium Lactate-Gluconate

122 Ethanolamine Oleate

123 Ethoxzolamide

Schedule 3—continued

124 Ethylnoradrenaline Hydrochloride

181 Lauryldimethylbenzyl Ammonium Chloride

125 Fenoterol Hydrobromide

182 Lavender Oil, Spike, B.P.C. 1968

126 Ferrous Aminoacetosulphate

183 Lead Subacetate Strong Solution, B.P.C.

127 Ferrous Phosphate Compound, Syrup, B.P.C. 1968

184 Lemon Oil Terpeneless, B.P.C.

128 Fluclorolone Acetonide

185 Lobelia Ethereal Tincture, B.P.C.

129 Flucytosine

186 Locasol

130 Flumethasone Pivalate

187 Lofenalac

131 Fluorometholone

188 Lypressin

132 Fluorouracil Sodium

189 Magenta, B.P.C.

133 Flurandrenolone

190 Magnesium-Aluminium Hydroxide

134 Fusidic Acid

191 Magnesium Chloride

135 “ GALACTOMIN, FORMULA No. 17 ”

192 Magnesium Hydroxide, B.P.C.

136 “ GALACTOMIN, FORMULA No. 19 ”

193 Maphenide Acetate

137 Gelsemium Tincture, B.P.C.

194 Mebhydrolin Napadisylate, B.P.C. 1968

138 Ginger Syrup, B.P.C.

195 Mecamylamine Hydrochloride, B.P. 1968

139 Glucagon Hydrochloride

196 Medroxyprogesterone Acetate

140 Glucose and Ketone Indicator

197 Medrysone

141 Glucose Indicator—Urine

198 Mefruside

142 “ GLUCOSE NUTRAMIGEN ”

199 Mercuric Chloride, B.P.C.

143 Glycerophosphate Compound Syrup, A.P.F. 1964

200 Methdilazine Hydrochloride

144 Glymidine

201 Methenolone Acetate

145 Goats’ Milk, Dehydrated

202 Methsuximide

146 Goats’ Milk, Whole (Sterilised)

203 Methyclothiazide

147 Gramicidin

204 Methylphenobarbitone B.P.C. 1963

148 Guaiphenesin, B.P.C.

205 Methylprednisolone Acetate

149 Haemodialysis Solutions. B.P.C.

206 Methylprednisolone Sodium Succinate

150 Hamamelis Liquid Extract, B.P.C.

207 Methysergide Maleate

151 Heparin Calcium

208 Metoclopramide Hydrochloride

152 Hexamine Hippurate

209 Minocycline Hydrochloride

153 Hexamine Mandelate

210 Mithramycin

154 Hydrallazine Hydrochloride

211 Morphine Tartrate

155 Hydrargaphen

212 Myrrh Tincture, B.P.C.

156 Hydromorphone Hydrochloride

213 Nalidixic Acid, B.P.C.

157 Hydroxyurea

214 Naphazoline Hydrochloride

158 Hyoscine Butylbromide

215 Natamycin

159 Hyoscyamine Sulphate

216 Neomycin Undecenoate

160 Hyoscyamus Liquid Extract, B.P.C.

217 Norgestrel

161 Hypromellose 4500, B.P.C.

218 Oestradiol Valerate

162 Ichthammol, B.P.C.

219 Oestrone, B.P.C. 1954

163 Influenza Vaccine—Sub Unit Type

220 Orange Syrup, B.P.C.

 (Deoxycholate Treated)

221 Orange Tincture, B.P.C.

164 Injection of Potassium Chloride with Sodium Lactate and Anhydrous Dextrose

222 Oxazepam

165 Insect Allergen Extract—Bull Ant

223 Oxethazaine

165 Insect Allergen Extract—Honey Bee

224 Oxycodone Pectinate

167 Insect Allergen Extract—Jumper Ant

225 Oxymel, B.P.C.

168 Insect Allergen Extract—Mosquito

226 Oxymetholone

169 Insect Allergen Extract—Paper Wasp

227 Oxyphenonium Bromide

170 Insulin Injection Neutral, Specially

228 Oxytocin

Purified—Monocomponent

229 Pancreatin Enzyme, U.S.N.F. XIII

171 Insulin Injection, specially purified

230 Pancrelipase

172 Insulin Isophane Injection, specially purified

231 Papaveretum, B.P.C.

173 Insulin Zinc Suspension (Amorphous), Specially Purified Injection—

232 Paraffin Liquid Light, B.P.C. 1963

Monocomponent

233 Paramethasone Acetate

174 Insulin Zinc Suspension, Specially Purified Injection—Monocomponent

234 Pectin

175 Intraperitoneal Dialysis Solutions, B.P.C.

235 Pempidine Tartrate, B.P. 1968

176 Iron Polymaltose Complex

236 Penicillinase

177 “ ISOMIL ”

237 Pericyazine

178 “ KETOVITE ” Liquid

238 Pheniramine Aminosalicylate

179 “ KETOVITE ” Tablets

239 Pheniramine Maleate

180 Lactulose

240 Phenoxymethylpenicillin, Benzathine

241 Phenoxymethylpenicillin, Hydrabamine

242 Phensuximide, B.P.C.

243 Phenytoin, B.P.C.

244 Phthalylsulphacetamide

245 Physostigmine, B.P.C.

246 Pilocarpine Hydrochloride, B.P.C.

247 Pindolol

Schedule 3—continued

248 Pituitary Hormone, Follicle-stimulating, Human

300 Sodium Lactate

249 Pituitary Hormone, Growth, Human

301 Sodium Nitroprusside

250 Pituitary (Posterior Lobe) Powdered, B.P.C.

302 Sorbide Nitrate

251 Pizotifen Malate

303 “ SOYALAC ”

252 “ PK AID I ”

304 Spectinomycin Dihydrochloride Pentahydrate

253 “ PK AID II ”

305 Squill Oxymel, B.P.C.

254 Plasma Substitute (Polypeptide)

306 Squill Syrup. B.P.C.

255 Polyisobutylene

307 Squill Tincture. B.P.C.

256 Polyoestradiol Phosphate

308 Staphylococcus Toxoid, B.P. 1968

257 Polyvinyl Alcohol

309 Stearic Acid, B.P.C.

258 Polyvinylpyrrolidone and Vinyl Acetate Copolymer

310 Sterculia. B.P.C.

259 Potassium Chlorate, B.P.C.

311 Stilboestrol Diphosphate

260 Potassium Effervescent Tablets

312 Stone Fish Antivenene

261 Pralidoxime Iodide

313 Stramonium Liquid Extract, B.P. 1968

262 Prazosin Hydrochloride

314 Sulphaphemizole, B.P.C. 1968

263 Prednisolone Acetate

315 Sulphasalazine

264 Prednisolone Steaglate

316 Sulphasymazine

265 Prednisolone Tertiarybutylacetate

317 Sulphurated Potash, B.P.C.

266 “ PREGESTIMIL ”

318 Sulphur Sublimed, B.P.C.

267 Procarbazine Hydrochloride

319 Surgical Cement

268 Prochlorperazine

320 Surgical Cement Solvent

269 Prochlorperazine Edisylate

321 Tacrine

270 Proflavine Hemisulphate, B.P.C.

322 Taipan Antivenene

271 Proscillaridin

323 Tartrazine, B.P.C. 1954

272 “ PROSOBEE ”

324 Terbutaline Sulphate

273 Pumilio Pine Oil, B.P.C.

325 “ TERIC N8 ”

274 Pyrantel Embonate

326 Testosterone Decanoate

275 Quillaia Tincture, B.P.C.

327 Testosterone Enanthate

276 Quinethazone

328 Testosterone Isocaproate

277 Quinidine Bisulphate

329 Tetracycline, B.P.C.

278 Rabies Vaccine (Duck Type)

330 Thiabendazole, B.P.C.

279 Rabies Vaccine (Serum Type)

331 Thiethylperazine Malate

280 Raspberry Syrup, B.P.C.

332 Thiethylperazine Maleate

281 Rauwolfia Alkaloids

333 Thioguanine

282 Rauwolfia Serpentina, B.P.C.

334 Thiopropazate Hydrochloride, B.P.C.

283 Red Back Spider Antivenene

335 Thonzonium Bromide

284 Rolitetracycline

336 Thonzylamine Hydrochloride

285 Rosemary Oil, B.P.C.

337 Tiger Snake Antivenene

286 Saccharin Tablets, B.P.C.

338 Tinidazole

287 Salicylamide

339 Titanium Dioxide, B.P.C.

288 Sea Wasp Antivenene

340 Tobramycin Sulphate

289 Secbutobarbitone Sodium

341 Tolazamide

290 Senega, Concentrated Infusion. B.P.C.

342 Tolu Syrup, B.P.C.

291 Siberian Fir Oil, B.P.C. 1949

343 Triethanolamine, B.P.C.

292 Silver Protein, B.P.C. 1968

344 “ TRIGLYDE ”

293 Silver Protein Mild, B.P.C. 1968

345 Trimeprazine Tartrate, B.P.C.

294 Snake Bite Antivenene—Polyvalent

346 Trimetaphan Camsylate B.P. 1968

295 “ SOBEE ”

347 Trioxysalen

296 Sodium Carboxymethylcellulose

348 Vasopressin Tannate

297 Sodium Citro-Tartrate

349 Verapamil Hydrochloride

298 Sodium Gluconate

350 “ ZERODOR ”

299 Sodium Hypochlorite Solution. Strong, B.P.C.

351 “ ZOFF ”

SCHEDULE 4 Regulation 12 and sub-regulation 35 (1)

Additives

1 Acetone, B.P.C.

18 Ether, Solvent, B.P.

2 Alcohol (95%), B.P.

19 Eucalyptus Oil, B.P.

3 Arachis Oil, B.P.

20 Honey, Purified, B.P.C.

4 Camphor, B.P.

21 Hypromellose 4500, B.P.C.

5 Caramel Solution, A.P.F.

22 Industrial Methylated Spirit,

6 Castor Oil, B.P.

B.P.

7 Chlorhexidine Acetate, B.P.C.

23 Linseed Oil

8 Chlorhexidine Gluconate Solution, B.P.

24 Maize Oil, B.P.

9 Chloroform, B.P.

25 Methylcellulose 20, B.P.C.

10 Cincole, B.P.C.

26 Methylcellulose 4500, B.P.C.

11 Citronella Oil, B.P.C.

27 Olive Oil, B.P.

12 Concentrated Anise Water, B.P.C.

28 Peppermint Oil, B.P.

13 Concentrated Cinnamon Water, B.P.C.

29 Saccharin Sodium, B.P.

14 Concentrated Peppermint Water, B.P.

30 Sodium Thiosulphate, B.P.C.

15 Dextrose, B.P.

31 Syrup of Pholcodine Citrate, B.P.C. 1959

16 Dilute Alcohols, B.P.

32 Turpentine Oil, B.P.

17 Ether, Anaesthetic, B.P.

33 Xylene, B.P.C. 194

SCHEDULE 5  Sub-regulations 14 (1), (2) and

(5), 19 (1), 21 (1) and 22 (2)

Pharmaceutical Benefits the Prescribing of which is Subject to Conditions and Restrictions

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

1

Acetylcysteine............................................

Bronchiectasis

Cystic fibrosis (mucoviscidosis)

2

Acrylic Resin

Ileostomy or colostomy conditions

3

“ ALBUMAID XP ”.................................

Phenylketonuria

4

Alginic Acid Compound.........................

With the written authority of the Director-General, cardio-oesophageal reflux

5

Alprenolol Injection, B.P..........................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

6

Alprenolol Tablets, B.P............................

Dissecting aneurysm (aortic)

Hypertension

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

7

Amantadine Hydrochloride.....................

The treatment of Parkinson’s disease caused otherwise than by treatment with a drug

8

(1) Aminocaproic Acid, B.P.

Treatment in hospital of patients suffering from severe haemorrhage associated with excessive fibrinolysis

(2) Aminocaproic Acid Injection, B.P.

9

“ AMINOGRAN ”

Phenylketonuria

10

Ascorbic Acid Tablets, B.P.

Any disease or condition in a pensioner

11

Azathioprine Tablets, B.P........................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General—

Anaemia, autoimmune haemolytic

Arthritis, rheumatoid with vasculitis or visceral complications

Continuing azathioprine therapy after discharge from an approved hospital

Crohn’s disease

Dermatomyositis

Granulomatosis, Wegener’s

Hepatitis, active, chronic

Lupus erythematosus, systemic

Nephritis

Nephrotic syndrome

Organ transplant

Pemphigus vulgaris

Polyarteritis nodosa

Pyoderma gangrenosum

Scleroderma

Thrombocytopenic purpura

Ulcerative colitis

12

Baclofen......................................................

With the written authority of the Director-General, spasticity due to multiple sclerosis or spinal cord lesions

13

“ BANISH ”................................................

Ileostomy or colostomy conditions

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

14

Beclomethasone Dipropionate metered aerosol spray

Chronic intractable asthma requiring maintenance corticosteroids

15

Benzoin Compound Tincture, B.P.C., Aerosol Spray

Ileostomy or colostomy conditions

16

Betamethasone Acetate with Betamethasone Injection

Alopecia areata

Granulomata, dermal

Keloid

Lichen planus hypertrophic

Lichen simplex chronicus

Local intra-articular or peri-articular infiltration

Lupus erythematosus, chronic discoid

Necrobiosis lipoidica

Uveitis

17

Bisacodyl Suppositories, B.P.

Any disease or condition in a paraplegic or quadriplegic patient

For use by patients who are receiving long-term intensive nursing care in hospitals or nursing homes

18

Bleomycin Sulphate..................................

Choriocarcinoma of the testis

Embryonal cell carcinoma of the testis

Lymphoma

Squamous cell carcinoma

19

(1) Calciferol, B.P......................................

With the written authority of the Director-General—

(2) Calciferol Tablets, Strong, B.P.

Hypocalcaemia

Hypoparathyroidism

Osteomalacia following gastrectomy, severe steatorrhoea or renal failure

Vitamin D-resistant rickets

20

Calcium Carbonate, B.P., with Calcium Lactate-Gluconate

With the written authority of the Director-General—

Hypocalcaemia

Osteoporosis

21

Calcium Carbonate, B.P., with Citric Acid, B.P., Compound Effervescent Tablets

With the written authority of the Director-General—

Hypocalcaemia

Osteoporosis

22

Calcium Folinate.......................................

Antidote to folic acid antagonists

23

Carbenicillin Sodium................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General—

Infections where positive bacteriological evidence confirms that carbenicillin is the most appropriate therapeutic agent

Septicaemia, suspected or proven

24

Carbenoxolone Tablets, B.P.

Gastric ulcer where a radiological examination or other tests have confirmed the presence of a gastric ulcer

25

(1) Cephalexin Capsules, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Cephalexin Tablets, B.P.....................

(3) Cephalexin. B.P., with Purified Water, B.P.

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephalexin monohydrate is the most appropriate therapeutic agent

26

Cephaloridine.............................................

Infections where positive bacteriological evidence confirms that cephaloridine is the most appropriate therapeutic agent

27

Cephalothin Sodium.................................

Infections where positive bacteriological evidence confirms that cephalothin sodium is the most appropriate therapeutic agent

28

Cephazolin Sodium...................................

Infections where positive bacteriological evidence’ confirms that cephazolin sodium is the most appropriate therapeutic agent

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

29

(1) Cephradine Capsules..........................

With the written authority of the Director-General, infections where positive bacteriological evidence confirms that cephradine is the most appropriate therapeutic agent

(2) Cephradine with Purified Water, B.P.

30

Cephradine for Injection

Infections where positive bacteriological evidence confirms that cephradine is the most appropriate therapeutic agent

31

Charcoal Tablets........................................

Ileostomy or colostomy conditions

32

Chlorambucil Tablets, B.P.......................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General—

Anaemia, autoimmune, haemolytic

Arthritis, rheumatoid with vasculitis or visceral complications

Continuing chlorambucil therapy after discharge from an approved hospital

Crohn’s disease

Dermatomyositis

Granulomatosis, Wegener’s

Hepatitis, active chronic

Lupus erythematosus, systemic

Malignant disease including leukaemia

Nephritis

Nephrotic syndrome

Polyarteritis nodosa

Scleroderma

Thrombocytopenic purpura

Ulcerative colitis

33

Chloramine Deodorant Tablets and Powder

Ileostomy or colostomy conditions

34

(1) Chloramphenicol Capsules, B.P.

Bacterial meningitis

Intraocular infections

(2) Chloramphenicol Sodium Succinate for Injection

Rickettsioses

Typhoid

(3) Chloramphenicol Palmitate Oral Suspension

The treatment of other serious infections in a patient where it is established by appropriate bacteriological testing that chloramphenicol is the only suitable antibiotic listed as a pharmaceutical benefit for use in treating the infection in the patient

35

(1) Chlormethiazole ..

For short term use in a hospital for alcohol or drug withdrawal therapy

(2) Chlormethiazole

Status epilepticus

Edisylate

36

Chlorotrianisene Tablets...........................

Carcinoma of the prostate

37

(1) Chlorpromazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Chlorpromazine Injection, B.P.

Chorea

Hyperactive states of organic or toxic delirium

(3) Chlorpromazine Tablets, B.P.

Major psychoses including—

Major organic psychoses including arteriopathic dementia

Manic-depressive psychosis

Paranoid states

Schizophrenia

Senile dementia

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct disorders in patients who have not attained the age of 16 years

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

38

Cholestyramine...........................................

With the written authority of the Director-General—

Bile salt malabsorption associated with ileal resection or proven ileal disease

Pruritus associated with partial biliary obstruction not responding to other therapy

Treatment of hypercholesterolemia

39

(1) Clindamycin Hydrochloride

Gram-positive coccal infections where the infection cannot be safely and affectively treated with penicillin or a derivative of penicillin

(2) Clindamycin Palmitate Hydrochloride

40

Clofibrate Capsules, B.P............................

With the written authority of the Director-General—

Diabetic retinopathy (exudative)

Initial treatment with clofibrate of hyperlipidaemia not responding to dietary therapy

A second or subsequent course of treatment of hyperlipidaemia where significant lowering of serum triglyceride or serum cholesterol subsequent to initial treatment with clofibrate has been established by laboratory report

41

Clonazepam................................................

Epilepsy

42

(1) Cloxacillin Capsules, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Cloxacillin Sodium, B.P., with Purified Water, B.P.

With the written authority of the Director-General—

Infections due to the presence of penicillin-resistant staphylococci

Osteomyelitis

43

(1) Codeine Phosphate with Aspirin, Soluble Tablets

Any disease or condition in a pensioner

(2) Codeine Phosphate with Aspirin and Paracetamol Tablets, 8mg-250mg-250mg tablets

44

Codeine Phosphate with Aspirin and Paracetamol Tablets, 30mg-225mg-150mg tablets

Malignant neoplasia

45

Colistin Sulphomethate Sodium, B.P., for injection

Pyocyaneus infection, other gram-negative infections where no other drug is effective

46

Cyanocobalamin Injection, B.P.

Neuroblastoma

Pernicious anaemia and other proven Vitamin B12 deficiencies

Post-gastrectomy treatment

Sub-acute combined degeneration of the cord

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

47

(1) Cyclophosphamide B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Cyclophosphamide Tablets, B.P.

With the written authority of the Director-General—

Anaemia, autoimmune, haemolytic

Arthritis, rheumatoid with vasculitis or visceral complications

Continuing cyclophosphamide therapy after discharge from an approved hospital

Crohn’s disease

Dermatomyositis

Granulomatosis, Wegener’s

Hepatitis, active, chronic

Lupus erythematosus, systemic

Malignant disease, including leukaemia

Nephritis

Nephrotic syndrome

Pemphigus vulgaris

Polyarteritis nodosa

Scleroderma

Thrombocytopenic purpura

Ulcerative colitis

48

Deodorant Detergent Solution (Lauryldimethylbenzyl Ammonium. Chloride and “ TERIC N8 ”)

Any disease or condition in a paraplegic or quadriplegie patient

Ileostomy or colostomy conditions

49

Dexamethasone Sodium Phosphate Injection equivalent of Dexamethasone Phosphate 120 mg in 5 ml

For use in a hospital

50

Dexamphetamine Tablets, B.P.

With the written authority of the Director-General—

For the treatment of a patient who has not attained the age of 21 years and who is hyperkinetic as a result of brain damage

Narcolepsy

51

(1) Dextromoramide Tablets, B.P.

Treatment in malignant neoplasia

(2) Dextromoramide Tartrate, B.P.

52

Dicyclomine Hydrochloride with Doxylamine Succinate and Pyridoxine Hydrochloride

Vomiting in pregnancy

53

“DIGESTELACT”.....................................

With the written authority of the Director-General, lactose intolerance

54

Dihydrotachysterol....................................

With the written authority of the Director-General—

Hypoparathyroidism

Osteomalacia following gastrectomy, severe steatorrhoea or renal failure

Vitamin D-resistant rickets

55

Dimethicone Aerosol Spray....................

Ileostomy or colostomy conditions

56

Dimethicone Creams................................

Any disease or condition in a paraplegic or quadriplegic patient

Use with surgical appliances

57

(1) Dioctyl Sodium Sulphosuccinate

Any disease or condition in a paraplegic or quadriplegic patient

(2) Dioctyl Sodium Sulphosuccinate with Bisacodyl

For use in patients who are receiving long-term intensive nursing care in hospitals or nursing homes

(3) Dioctyl Sodium Sulphosuccinate with Danthron

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whoso treatment it may be prescribed) for supply under Part VII of the Act

58

Diphemanil Methylsulphate

Amputees

Any disease or condition in a paraplegic or quadriplegic patient

59

Dipyridamole..............................................

Supplementing anticoagulants in—

Biopsy proven glomerulonephritis

Microangiopathic renal disease

Renal allograft

Patients with cardiac prosthesis

60

Droperidol....................................................

Any disease or condition in a patient receiving treatment in a hospital

61

Ethyloestrenol Tablets, B.P.

With the written authority of the Director-General—

Osteoporosis

Patients on long-term treatment with corticosteroids

62

Flucytosine

Invasive or systemic fungal infections such as candidiasis, cryptococcosis and chromoblastomycosis

63

Fluoxymesterone Tablets, B.P.

Carcinoma of the breast

Hypogonadism

With the written authority of the Director-General—

Aplastic anaemias, proven

Osteoporosis

64

(1) Fluphenazine Decanoate Injection, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Fluphenazine Enanthate Injection, B.P.

Chorea

Hyperactive states of organic or toxic delirium

(3) Fluphenazine Hydrochloride, B.P.

Major psychoses including—

Major organic psychoses including arteriopathic dementia

(4) Fluphenazine Tablets, B.P.

Manic-depressive psychosis

Paranoid states

Schizophrenia

Senile dementia

Malignant neoplasia (late stage)

Radiation sickness

65

(1) Folic Acid, B.P.....................................

Cystic fibrosis

(2) Folic Acid Tablets, B.P., 5 mg

Haemolytic anaemia, chronic

Proven folic acid deficiency

Sprue or the sprue-like syndrome

66

Frusemide Tablets, B.P., 500 mg

Renal failure

67

Fusidic Acid................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence

68

“ GALACTOMIN FORMULA No. 17 ”

With the written authority of the Director-General—

Galactosaemia

Conditions needing an extreme restriction of lactose in the diet of a patient who has not attained the age of 4 years

69

“ GALACTOMIN FORMULA No. 19 ”

With the written authority of the Director-General, glucose-galactose malabsorption

70

Gentamicin Injection, B.P........................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General—

Infections where positive bacteriological evidence confirms that gentamicin sulphate is the most appropriate antibiotic

Septicaemia including suspected septicaemia

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

71

“ GLUCOSE NUTRAMIGEN ”

With the written authority of the Director-General—

Cows’ milk allergy in children who have not attained the age of 2 years

Cystic fibrosis (mucoviscidosis)

Galactosaemia

Lactose intolerance

72

Glycerol Suppositories, B.P.

Any disease or condition in a paraplegic or quadriplegic patient

For use by patients who are receiving long-term intensive nursing care in hospitals or nursing homes

73

Goats’ Milk, Dehydrated..........................

With the written authority of the Director-General, cows’ milk allergy in children who have not attained the age of 2 years

74

Goats’ Milk, Whole (Sterilized)

With the written authority of the Director-General, cows’ milk allergy in children who have not attained the age of 2 years

75

Griseofulvin Tablets, B.P..........................

With the written authority of the Director-General—

For use in recalcitrant tinea infections due to Microsporum, Trichophyton or Epidermophyton species proven by pathology testing, or, in the case of the scalp, by pathology testing or by Wood’s Light examination

Kerion

76

(1) Haloperidol...........................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Haloperidol Tablets, B.P.

Chorea

Hyperactive states of organic or toxic delirium

Malignant neoplasia (late stage)

Radiation sickness

Major psychoses including—

Major organic psychoses including arteriopathic dementia

Manic-depressive psychoses

Paranoid states

Schizophrenia

Senile dementia

77

(1) Hydrochlorothiazide, B.P., with Amiloride Hydrochloride

Cardiac failure

(2) Hydrochlorothiazide, B.P., with Triamterene, B.P.

78

Hydrocortisone Acetate Injection, B.P.

Alopecia areata

Granulomata, dermal

Keloid

Lichen planus hypertrophic

Lichen simplex chronicus

Local intra-articular or peri-articular infiltration

Lupus erythematosus, chronic discoid

79

Hydrocortisone Sodium Succinate Injection, 500 mg

Any disease or condition in a patient receding treatment in a hospital

80

Hydroxocobalamin Injection, B.P.

Neuroblastoma

Pernicious anaemia and other proven Vitamin B12 deficiencies

Post-gastrectomy treatment

Sub-acute combined degeneration of the cord

81

Ibuprofen Tablets.......................................

Osteoarthritis where salicylates are contra-indicated or ineffective

Rheumatoid arthritis where salicylates are contraindicated or ineffective

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

82

(1) Idoxuridine Eye Drops......................

Infections caused by Herpes Simplex Virus or by Vaccinia Virus

(2) Idoxuridine Eye Ointment

83

Influenza Vaccine....................................

For prophylaxis of—

pensioners

persons suffering from any severe debilitating disease, chronic heart disease or chronic pulmonary disease

84

“ ISOMIL ”................................................

With the written authority of the Director-General—

Cows’ milk allergy in children who have not attained the age of 2 years

Galactosaemia

Homocystinuria

Lactose intolerance

85

Kanamycin Injection, B.P.......................

Infections where positive bacteriological evidence confirms that kanamycin sulphate is the most appropriate antibiotic

Septicaemia, including suspected septicaemia

86

(1) “ KETOVITE ” Liquid......................

With the written authority of the Director-General—

(2) “ KETOVITE ” Tablets....................

Galactosaemia

Persistent monosaccharide intolerance

Phenylketonuria

Tyrosinosis (hereditary)

87

Lactulose....................................................

Hepatic coma or pre-coma (chronic portosystemic encephalopathy)

88

Levodopa, B.P., with Carbidopa

With the written authority of the Director-General, treatment of Parkinson’s Disease

89

(1) Levodopa Capsules, B.P.

Treatment of Parkinson’s Disease

(2) Levodopa Tablets, B.P.

90

(1) Lignocaine Hydrochloride, B.P., Injection

Cardiac arrhythmias

(2) Lignocaine Hydrochloride Injection, B.P.

91

Lincomycin Hydrochloride, B.P.

Osteomyelitis

92

Lincomycin Injection, B.P......................

Gram-negative anaerobic infections

Gram-positive coccal infections where these cannot be safely and effectively treated with penicillin or a derivative of penicillin

93

Lithium Carbonate Tablets, B.P.

Manic depression

94

Locasol.......................................................

With the written authority of the Director-General—

Hypercalcaemia in children who have not attained the age of 2 years

Osteopetrosis

95

Lofenalac...................................................

Phenylketonuria

96

Maphenide Acetate..................................

Treatment, in a hospital, of burns

97

(1) Medroxyprogesterone Acetate Injections, 50 mg in 1 ml

Malignant neoplasia

Precocious puberty

(2) Medroxyprogesterone Acetate Injections, 150 mg in 1 ml

98

Medroxyprogesterone Acetate Tablets, 2.5 mg

Precocious puberty

Turner’s syndrome

99

Medroxyprogesterone Acetate Tablets, 10 mg

Malignant neoplasia

Precocious puberty

Turner’s syndrome

100

Medroxyprogesterone Acetate Tablets, 100 mg

Malignant neoplasia

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

101

(1) Metformin Hydrochloride, B.P.

With the written authority of the Director-General, maturity onset diabetes in patients who have not attained the age of 65 years in whom the risk of lactic acidosis is negligible, where the illness has not been satisfactorily controlled by diet and other drugs

(2) Metformin Tablets, B.P....................

102

(1) Methadone Injection, B.P.

Disabling pain associated with malignant neoplasia or self-limiting disorders of short duration where the patient has not responded to non-narcotic analgesics

(2) Methadone Tablets, B.P...................

103

(1) Methandienone Tablets, B.P.

With the written authority of the Director-General—

Osteoporosis

(2) Methenolone Acetate.......................

Patients on long-term treatment with corticosteroids

104

Methicillin Sodium, B.P., for injection

Proven or suspected staphylococcal septicaemia

105

(1) Methotrexate Injection....................

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Methotrexate Tablets.......................

With the written authority of the Director-General—

Continuing methotrexate therapy after discharge from an approved hospital

Malignant neoplasia

Pemphigus vulgaris

Severe intractable or extensive psoriasis

106

Methylphenobarbitone...........................

Epilepsy

107

Methylprednisolone Acetate Injection

For local intra-articular or peri-articular infiltration

Intrathecal use

108

Methylprednisolone Acetate Retention Enema

Proctitis

Ulcerative colitis

109

Methyltestosterone Tablets, B.P., 5 mg

Hypogonadism in patients who have not attained the age of 16 years

110

(1) Methyltestosterone, B.P...................

Carcinoma of the breast

(2) Methylestosterone Tablets, B.P., 25 mg or 50 mg

Hypogonadism

Klinefelter’s syndrome (seminiferous tubule dysgenesis)

111

Methysergide Malcate

Carcinoid syndrome

Prevention of disabling migraine when other treatment has failed

112

Mithramycin.............................................

For use in a hospital for—

Inoperable testicular neoplasm

Symptomatic hypercalcaemia and hypercalcinuria associated with advanced neoplasia

113

Morphine Sulphate, B.P., with Tacrine, Tablets

Severe intractable pain

114

Nalidixic Acid..........................................

Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nalidixic acid or where the patient is sensitive to sulphonamides

115

Nandrolone Decanoate Injection, B.P.

Carcinoma of the breast

With the written authority of the Director-General—

Osteoporosis

Patients on long-term treatment with corticosteroids

116

Nandrolone Phenylpropionate Injection, B.P.

Carcinoma of the breast

With the written authority of the Director-General—

Osteoporosis

Patients on long-term treatment with corticosteroids

117

Neomycin Tablets, B.P...........................

Acute leukaemia during induction of remission with chemotherapy

Bowel sterilization preparatory to major surgery

Encephalopathy, hepatic

Enteropathogenic E. coli infections in infants

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

118

Nicotinic Acid Tablets, B.P.

Any disease or condition in a pensioner

119

(1) Nitrofurantoin Oral Suspension

Urinary tract infections by organisms where sulphonamide treatment has proved ineffective and positive bacteriological evidence confirms that the organisms are sensitive to nitrofurantoin or where the patient is sensitive to sulphonamides

(2) Nitrofurantoin Tablets, B.P.

120

Norethisterone Acetate, B.P., Tablets, 10 mg

Carcinoma of the breast

Carcinoma of the endometrium

121

Norethisterone Acetate, B.P., Tablets, 2.5 mg

Endometriosis

Metropathia haemorrhagica

Precocious puberty

Turner’s syndrome

122

Norethisterone Tablets, B.P., 5 mg

Benign mammary dysplasia

Endometriosis

Metropathia haemorrhagica

Precocious puberty

Turner’s syndrome

123

Orphenadrine Hydrochloride Tablets, B.P.

Parkinsonism

124

Oxprenolol Hydrochloride, B.P., Injection................................................

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Dissecting aneurysm (aortic)

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Serious arrhythmias

Thyrotoxicosis

125

Oxprenolol Tablets, B.P..........................

Dissecting aneurysm (aortic)

Hypertension

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

126

Oxycodone Pectinate...............................

Treatment in malignant neoplasia

127

Oxymetholone..........................................

With the written authority of the Director-General—

Proven aplastic anaemias

Myelosclerosis

128

(1) Pancreatin, B.P.

Cystic fibrosis (mucoviscidosis)

(2) Pancreatin Enzyme 4X U.S.N.F.XIII strength

Following pancreatico-duodenectomy

Pancreatic steatorrhoea

(3) Pancrelipase

129

(1) Paraffin Liquid Emulsion

Any disease or condition in a paraplegic or quadriplegic patient

(2) Paraffin Liquid Emulsion with Phenolphthalein

Patients who are receiving the Supplementary Intensive Nursing Home Care Benefit

130

(1) Penicillamine Capsules, B.P.

With the written authority of the Director-General—

Acute heavy metal intoxication

(2) Penicillamine B.P. Tablets,

Cystinosis

Cystinuria with calculus formation

Haemoglobinuria, paroxysmal cold

Wilson’s disease (hepatolenticular degeneration)

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

131

Pericyazine................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

Chorea

Hyperactive states of organic or toxic delirium

Major psychoses, including—

Major organic psychoses including arteriopathic dementia

Manic-depressive psychosis

Paranoid states

Schizophrenia

Senile dementia

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct disorders in patients who have not attained the age of 16 years

132

Phenelzine Tablets, B.P...........................

Depressive illness resistant to treatment with tricyclic antidepressants or electro-compulsive therapy

Obsessive compulsive neurosis

133

(1) Phenformin Hydrochloride, B.P.

With the written authority of the Director-General, maturity onset diabetes in patients who have not attained the age of 65 years in whom the risk of lactic acidosis is negligible, where the illness has not been satisfactorily controlled by diet or other drugs

(2) Phenformin Tablets, B.P.

134

Phenobarbitone Tablets, B.P.

Epilepsy

135

Pindolol Injection....................................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

136

Pindolol Tablets.......................................

Dissecting aneurysm (aortic)

Hypertension

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

137

Pizotifen Malate.......................................

Prevention of migraine

138

(1) “ PK AID I ”.......................................

Phenylketonuria

(2) “ PK AID II ”

139

Polyisobutylene........................................

Ileostomy or colostomy conditions

140

Polyoestradiol Phosphate

Carcinoma of the breast

Carcinoma of the prostate

141

Polyvinylpyrrolidone and Vinyl Acetate Copolymer

Ileostomy or colostomy conditions

142

Prazosin Hydrochloride...........................

Supplementing beta-blockade in the treatment of hypertension

143

(1) Prednisolone Acetate Injection

Local intra-articular or peri-articular infiltration

(2) Prednisolone Tertiarybutylacetate Injection

144

Prednisolone Acetate with Phenylephrine Hydrochloride, B.P.

Corneal grafts

Uveitis

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject, to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part, VII. of the Act

145

Prednisolone Sodium Phosphate Retention Enema and Suppository

Ulcerative colitis

Proctitis

146

“ PREGESTIMIL ”..............................

With the written authority of the Director-General—

Cystic fibrosis

Multiple disaccharidase deficiency

147

Propranolol Injection, B.P..................

Dissecting aneurysm (aortic)

Idiopathic hypertrophic subaortic; stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

148

(1) Propranolol Tablets, B.P., 10 mg and 40 mg

Benign essential tremor (not Parkinsonian tremor).

Dissecting aneurysm (aortic)

Hypertension

Idiopathic hypertrophic subaortic stenosis

Right ventricular outflow tract obstruction

Serious arrhythmias

The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found

Thyrotoxicosis

(2) Propranolol Tablets, B.P., 160 mg

With the written authority of the Director-General—

Hypertension where there is an inadequate response to a daily dose of at least 160 mg of propranolol

Frequent disabling angina without evidence of cardiac failure where there is an inadequate response to a daily dose of at least 160 mg of propranolol

149

“ PROSOBEE ”.......................................

With the written authority of the Director-General—

Cows’ milk allergy in children who have not attained the age of 2 years

Galactosaemia

Homocystinuria

Lactose intolerance

150

Pyridoxine Hydrochloride Tablets

Anaemia proved to be responsive to pyridoxine

Convulsions responsive to pyridoxine

Homocystinuria

Primary hyperoxaluria

Radiation sickness

Sideroblastic (refractory) anaemia

Treatment and prophylaxis of peripheral neuritis caused or likely to be caused by isoniazid therapy

151

Riboflavine Tablets.................................

Any disease or condition in a pensioner

152

“ SOBEE ”................................................

With the written authority of the Director-General—

Cows’ milk allergy in children who have not attained the age of 2 years

Galactosaemia

Homocystinuria

Lactose intolerance

153

Sodium Carboxymethylcellulose with Pectin and Gelatin

Ileostomy or colostomy conditions

154

Sodium Fusidate......................................

Any disease or condition in a patient receiving treatment in or at an approved hospital

With the written authority of the Director-General, for use in combination with another antibiotic in the treatment of serious staphylococcal infections confirmed by bacteriological evidence

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII of the Act

155

Sodium Nitroprusside for infusion

For use in a hospital

156

“ SOYALAC ”..........................................

With the written authority of the Director-General—

Cows’ milk allergy in children who have not attained the age of 2 years

Galactosaemia

Homocystinuria

Lactose intolerance

157

Spironolactone Tablets, B.P.

To supplement other diuretics when these have proved inadequate

Myasthenia gravis

Primary hyperaldosteronism

Secondary hyperaldosteronism

158

Stanolone Tablets, B.P............................

Carcinoma of the breast

With the written authority of the Director-General—

Osteoporosis

Patients on long-term treatment with corticosteroids

159

Sterculia.....................................................

Ileostomy or colostomy conditions

160

Stilboestrol Diphosphate........................

Carcinoma of the prostate

161

Streptokinase, B.P....................................

Any disease or condition in a patient receiving treatment in a hospital

162

(1) Surgical Cement................................

Any disease or condition in a paraplegic or quadriplegic patient

(2) Surgical Cement Solvent

For use with surgical appliances

Ileostomy or colostomy conditions

163

(1) Testosterone Enanthate....................

Carcinoma of the breast

(2) Testosterone Propionate Injection, B.P.

Hypogonadism

Klinefelter’s syndrome (seminiferous tubule dysgenesis)

164

(1) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P. and Testosterone Isocaproate

Carcinoma of the breast

Gigantism

Hypogonadism

Klinefelter’s syndrome (seminiferous tubule dysgenesis)

(2) Testosterone Propionate, B.P., with Testosterone Phenylpropionate, B.P., Testosterone Isocaproate and Testosterone Decanoate

165

Tetracosactrin Acetate, B.P.

With the written authority of the Director-General—

Hypsarrhythmia

Multiple sclerosis, acute exacerbation

Status asthmaticus

Treatment of children who need long-term corticosteroid therapy but who are in danger of growth suppression as a result

Treatment of patients who are being withdrawn from long-term corticosteroid therapy

Ulcerative colitis, proven, not responding to parenteral corticosteroids

166

Tetracosactrin Zinc Injection, B.P.

With the written authority of the Director-General—

Hypsarrhythmia

Multiple sclerosis, acute exacerbation

Status asthmaticus

Treatment of children who need long-term corticosteroid therapy but who are in danger of growth suppression as a result

Treatment of patients who are being withdrawn from long-term corticosteroid therapy

Ulcerative colitis, proven, not responding to parenteral corticosteroids

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

167

Thiamine Hydrochloride Tablets, B.P.

In or at an approved hospital

168

Thioguanine..............................................

Leukaemia

169

Thiopropazate Hydrochloride

Chorea

Drug induced dystonias

170

(1) Thioridazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Thioridazine Tablets, B.P.

Chorea

Hyperactive states of organic or toxic delirium

Major psychoses including—

Major organic psychoses including arteriopathic dementia

Manic-depressive psychosis

Paranoid states

Schizophrenia

Senile dementia

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct disorders in patients who have not attained the age of 16 years

171

Tobramycin Sulphate..............................

With the written authority of the Director-General—

Infections where positive bacteriological evidence confirms that tobramycin sulphate is the most appropriate antibiotic

Septicaemia, suspected or proven

172

Tranylcypromine Tablets, B.P.

Depressive illness resistant to treatment with tricyclic anti-depressants or electro-convulsive therapy

Obsessive compulsive neurosis

173

Triamcinolone Acetonide Injection

Alopecia areata

Granulomata, dermal

Keloid

Lichen planus hypertrophic

Lichen simplex chronicus

Lupus erythematosus, chronic discoid

Necrobiosis lipoidica

174

(1) Trifluoperazine Hydrochloride, B.P.

Any disease or condition in a patient receiving treatment in or at an approved hospital

(2) Trifluoperazine Tablets, B.P.

Chorea

Hyperactive states of organic or toxic delirium

Major psychoses including—

Major organic psychoses including arteriopathic dementia

Manic-depressive psychosis

Paranoid states

Schizophrenia

Senile dementia

Malignant neoplasia (late stage)

Radiation sickness

Severe conduct disorders in patients who have not attained the age of 16 years

175

“ TRIGLYDE ”........................................

Patients requiring a ketogenic diet for intractable childhood epilepsy

With the written authority of the Director-General, proven malabsorption

176

Trioxysalen...............................................

Vitiligo

177

Vancomycin Hydrochloride...................

Any disease or condition in a patient receiving treatment in a hospital

178

Verapamil Hydrochloride.......................

Cardiac arrhythmias

Schedule 5—continued

Column 1

Column 2

Column 3

Item

Pharmaceutical benefit

Purpose for which, and the conditions subject to which, the pharmaceutical benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act

179

“ ZERODOR ”.........................................

Ileostomy or colostomy conditions

180

“ ZOFF ”...................................................

Any disease or condition in a paraplegic or quadriplegic patient

For use with surgical appliances

Ileostomy or colostomy conditions

                             

Printed by Authority by the Acting Commonwealth Government Printer

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0